These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 17459043)

  • 1. Use of oral glycopyrronium bromide in hyperhidrosis.
    Bajaj V; Langtry JA
    Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis.
    Paller AS; Shah PR; Silverio AM; Wagner A; Chamlin SL; Mancini AJ
    J Am Acad Dermatol; 2012 Nov; 67(5):918-23. PubMed ID: 22405644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral glycopyrrolate for refractory pediatric and adolescent hyperhidrosis.
    Kumar MG; Foreman RS; Berk DR; Bayliss SJ
    Pediatr Dermatol; 2014; 31(1):e28-30. PubMed ID: 24266878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine.
    Walling HW
    J Am Acad Dermatol; 2012 Mar; 66(3):387-92. PubMed ID: 21820204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craniofacial hyperhidrosis successfully treated with topical glycopyrrolate.
    Luh JY; Blackwell TA
    South Med J; 2002 Jul; 95(7):756-8. PubMed ID: 12144084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of thoracoscopic sympathectomy over medical management for the palmoplantar subset of severe hyperhidrosis.
    Baumgartner FJ; Bertin S; Konecny J
    Ann Vasc Surg; 2009; 23(1):1-7. PubMed ID: 18619780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A medical alternative to the treatment of compensatory sweating.
    Cladellas E; Callejas MA; Grimalt R
    Dermatol Ther; 2008; 21(5):406-8. PubMed ID: 18844718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral glycopyrrolate after the failure of oral oxybutynin in the treatment of primary hyperhidrosis.
    Del Boz J; Millán-Cayetano JF; Rivas-Ruiz F; de Troya-Martín M
    Br J Dermatol; 2017 Mar; 176(3):821-823. PubMed ID: 27436700
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy of oral anticholinergics for sympathetic overactivity in a thoracic surgery clinic.
    Hynes CF; Seevaratnam S; Gesuwan K; Margolis M; Marshall MB
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):565-8. PubMed ID: 27160942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
    Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok RD; Quiring J; Drew J; Pariser DM
    Am J Clin Dermatol; 2019 Aug; 20(4):593-604. PubMed ID: 31111409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycopyrronium (Qbrexza) Topical Wipes for Hyperhidrosis.
    Arnold MJ; O'Connor C
    Am Fam Physician; 2019 Sep; 100(6):372-373. PubMed ID: 31524358
    [No Abstract]   [Full Text] [Related]  

  • 12. Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
    Pariser DM; Lain EL; Mamelok RD; Drew J; Mould DR
    Clin Pharmacokinet; 2021 May; 60(5):665-676. PubMed ID: 33433785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of gloves when applying topical glycopyrronium for treatment of primary axillary hyperhidrosis.
    Siscos SM; Figenshau K; Rajpara A
    J Am Acad Dermatol; 2020 Oct; 83(4):e275. PubMed ID: 31846717
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical glycopyrrolate for patients with facial hyperhidrosis.
    Kim WO; Kil HK; Yoon KB; Yoon DM
    Br J Dermatol; 2008 May; 158(5):1094-7. PubMed ID: 18294315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique pattern of hyperhidrosis.
    Lewis VJ; Holt PJ
    Arch Dermatol; 2006 Feb; 142(2):264. PubMed ID: 16490867
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful treatment of diabetic gustatory hyperhidrosis with topical glycopyrrolate].
    Lund NS; Maxel T; Rungby J
    Ugeskr Laeger; 2011 Sep; 173(36):2200-1. PubMed ID: 21893005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis.
    Nwannunu CE; Limmer AL; Coleman K; Shah R; Patel RR; Mui UN; Tyring SK
    Skin Therapy Lett; 2019 Mar; 24(2):1-3. PubMed ID: 30970203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary retention caused by topical glycopyrrolate for hyperhidrosis.
    Madan V; Beck MH
    Br J Dermatol; 2006 Sep; 155(3):634-5. PubMed ID: 16911300
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.
    Wolosker N; de Campos JR; Kauffman P; Puech-Leão P
    J Vasc Surg; 2012 Jun; 55(6):1696-700. PubMed ID: 22341836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Hotline: Topical glycopyrrolate: a successful treatment for craniofacial hyperhidrosis and eccrine hidrocystomas.
    Garnacho Saucedo GM; Moreno Jiménez JC; Jiménez Puya R; Rodríguez Bujaldon A
    Dermatol Ther; 2010; 23(1):94-7. PubMed ID: 20136914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.